R. Dhar (Kolkata (West Bengal), India), H. Keir (Dundee (Angus), United Kingdom), A. O'Donnell (Washington, United States of America), M. Torres Redondo (Matosinhos, Portugal)
Chest radiographs following admission with community acquired pneumonia: a retrospective audit
S. Upperton (Wakefield, United Kingdom), A. Dwarakanath (Wakefield, United Kingdom), A. Ameri (Wakefield, United Kingdom)
|   |
Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients
M. Oriano (Milano, Italy), L. Terranova (Milano, Italy), G. Sotgiu (Sassari, Italy), L. Saderi (Sassari, Italy), A. Bellofiore (Milano, Italy), M. Retucci (Milano, Italy), C. Marotta (Milano, Italy), A. Gramegna (Milano, Italy), D. Miglietta (Parma, Italy), C. Carnini (Parma, Italy), P. Marchisio (Milano, Italy), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milano, Italy), F. Blasi (Milano, Italy)
| |
Comparison of safety and efficacy between clarithromycin- and azithromycin-containing regimens in Mycobacterium avium complex lung disease
S. Kim (Seoul, Republic of Korea), Y. Kwon (Seoul, Republic of Korea), B. Kwon (Seoul, Republic of Korea), O. Kim (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea), Y. Chong (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea)
| |
Derivation und Validation of a Primary Ciliary Dyskinesia Computed Tomography (PCD-CT) Score in patients with bronchiectasis
J. Rademacher (Hannover, Germany), S. Dettmer (Hannover, Germany), J. Fuge (Hannover, Germany), J. Vogel-Claussen (Hannover, Germany), H. Shin (Hannover, Germany), A. Shah (London, United Kingdom), P. Pedro (London, United Kingdom), R. Wilson (London, United Kingdom), T. Welte (Hannover, Germany), F. Wacker (Hannover, Germany), F. Ringshausen (Hannover, Germany), M. Loebinger (London, United Kingdom)
| |
The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia
K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), T. Kireieieva (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine)
| |
Inhaled antibiotic treatment reduces the frequency of infective exacerbations in bronchiectasis: a single center, real life study
S. Nazzal (Haifa , Israel), Y. Adir (Haifa , Israel), R. Cohen (Haifa , Israel), N. Stein (Haifa , Israel), M. Shteinberg (Haifa , Israel)
| |
Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
N. Kwak (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), J. Cho (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), S. Choi (Seoul, Republic of Korea), C. Lee (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), J. Yim (Seoul, Republic of Korea)
| |
Respiratory viruses in adults with cystic fibrosis during stable and exacerbations
L. Terranova (Milan, Italy), A. Gramegna (Milan, Italy), M. Oriano (Milan, Italy), M. Pappalettera (Milan, Italy), M. Contarini (Milan, Italy), A. Colombo (Milan, Italy), F. Nava (Milan, Italy), F. Amati (Milan, Italy), A. Bellofiore (Milan, Italy), C. Marotta (Milan, Italy), P. Marchisio (Milan, Italy), S. Aliberti (Milan, Italy), F. Blasi (Milan, Italy)
| |
Dueling diseases - seven cases of Swyer-James-MacLeod syndrome in non-CF bronchiectasis adult patients
O. Munteanu (Chisinau, Republic of Moldova), I. Volosciuc (Chisinau, Republic of Moldova), D. Chesov (Chisinau, Republic of Moldova), L. Onea (Chisinau, Republic of Moldova), A. David (Chisinau, Republic of Moldova), V. Botnaru (Chisinau, Republic of Moldova)
| |
Prevalence of relevant multi-drug resistant (MDR) pathogens in a bronchiectasis (BE) cohort.
J. Perez (Barcelona, Spain), E. Polverino (Barcelona, Spain), A. Alvares (Barcelona, Spain), P. Chang (Barcelona, Spain), L. Traversi (Varese, Italy), A. Rando (Barcelona, Spain), D. Romero (Barcelona, Spain), M. Martin (Barcelona, Spain)
| |
Number of exacerbations and Pseudomonas aeruginosa colonization negatively impact on the radiological severity in Primary Ciliary Dyskinesia.
A. Farolfi (Milan, Italy), L. Barcellini (Milan, Italy), G. Zuccotti (Milan, Italy), U. Ambrosetti (Milan, Italy), M. De Santi (Milan, Italy), M. Patria (Milan, Italy), D. Consonni (Milan, Italy), G. Piatti (Milan, Italy)
| |
Prevalence of S. pneumoniae colonization and serotypes in sputum of vaccine-naive adults with cystic fibrosis.
L. Terranova (Milan, Italy), A. Gramegna (Milan, Italy), M. Oriano (Milan, Italy), M. Pappalettera (Milan, Italy), M. Contarini (Milan, Italy), L. Ruggiero (Milan, Italy), A. Colombo (Milan, Italy), F. Amati (Milan, Italy), M. Retucci (Milan, Italy), O. Chiappa (Milan, Italy), P. Marchisio (Milan, Italy), S. Aliberti (Milan, Italy), F. Blasi (Milan, Italy)
| |
The Significance of IgG to Aspergillus in Non-Cystic Fibrosis Bronchiectasis
C. Huntley (Wolverhampton, United Kingdom), P. Chohan (Wolverhampton, United Kingdom), K. Yip (Wolverhampton, United Kingdom), R. Carter (Wolverhampton, United Kingdom)
| |
Nontuberculous mycobacteria in patients with bronchiectasis: data from the German Bronchiectasis Registry PROGNOSIS
R. Ewen (Hannover, Germany), G. Barten-Neiner (Hannover, Germany), A. De Roux (Berlin, Germany), R. Diel (Kiel, Germany), P. Mertsch (Munich, Germany), J. Rademacher (Hannover, Germany), T. Welte (Hannover, Germany), A. Zurawski (Hannover, Germany), F. Ringshausen (Hannover, Germany), +. The Prognosis Study Group (Hannover, Germany)
| |
Persistent bacterial bronchitis in adults – a precursor to Bronchiectasis?
S. Finch (Dundee, United Kingdom), L. Carreto (Lisbon, Portugal), A. Hani (Dundee, United Kingdom), A. Browne (Dundee, United Kingdom), T. Fardon (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Endobronchial valve treatment for cavitary pulmonary diseases caused by non-tuberculosis mycobacteria.
A. Russkikh (Moscow, Russian Federation), A. Gracheva (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
| |
Clinical efficacy and safety evaluation of a novel seawater-based hypertonic solution in common cold patients
S. Anapurapu (Milan, Italy), A. Bonagoni (Milan, Italy), W. Hooper (Princeton, United States of America), A. SAAID (Levallois-Perret, France), N. Durand (Levallois-Perret, France), C. Houee (Levallois-Perret, France), M. Alegre (Folkestone, United Kingdom)
| |
Comparison of clinical characteristics of invasive tracheobronchial aspergillosis with or without invasive pulmonary aspergillosis
C. Pak (Ulsan, Republic of Korea), J. Jeong (Ulsan, Republic of Korea), H. Cha (Ulsan, Republic of Korea), E. Choi (Daegu, Republic of Korea), T. Lee (Ulsan, Republic of Korea), K. Seo (Ulsan, Republic of Korea), Y. Jegal (Ulsan, Republic of Korea), J. Ahn (Ulsan, Republic of Korea), S. Ra (Ulsan, Republic of Korea)
| |
Efferent therapy in complex treatment of community-acquired pneumonia in patients with immunosuppression
O. Viltsaniuk (Vinnytsya, Ukraine), Y. Mostovoy (Vinnytsya, Ukraine)
| |